4-154569192-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005141.5(FGB):​c.843G>T​(p.Val281Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00379 in 1,614,090 control chromosomes in the GnomAD database, including 180 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 96 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 84 hom. )

Consequence

FGB
NM_005141.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.291

Publications

3 publications found
Variant links:
Genes affected
FGB (HGNC:3662): (fibrinogen beta chain) The protein encoded by this gene is the beta component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Fibrinogen serves key roles in hemostasis and antimicrobial host defense. Mutations in this gene lead to several disorders, including afibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia and thrombotic tendency. [provided by RefSeq, Aug 2020]
FGB Gene-Disease associations (from GenCC):
  • congenital fibrinogen deficiency
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • thrombophilia
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital afibrinogenemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • familial dysfibrinogenemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial hypofibrinogenemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 4-154569192-G-T is Benign according to our data. Variant chr4-154569192-G-T is described in ClinVar as Benign. ClinVar VariationId is 259649.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.291 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0663 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGBNM_005141.5 linkc.843G>T p.Val281Val synonymous_variant Exon 6 of 8 ENST00000302068.9 NP_005132.2 P02675V9HVY1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGBENST00000302068.9 linkc.843G>T p.Val281Val synonymous_variant Exon 6 of 8 1 NM_005141.5 ENSP00000306099.4 P02675
FGBENST00000509493.1 linkc.186G>T p.Val62Val synonymous_variant Exon 4 of 6 5 ENSP00000426757.1 D6REL8
FGBENST00000502545.5 linkn.824G>T non_coding_transcript_exon_variant Exon 6 of 7 5

Frequencies

GnomAD3 genomes
AF:
0.0199
AC:
3029
AN:
152152
Hom.:
96
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0686
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00812
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.0168
GnomAD2 exomes
AF:
0.00521
AC:
1309
AN:
251364
AF XY:
0.00399
show subpopulations
Gnomad AFR exome
AF:
0.0677
Gnomad AMR exome
AF:
0.00376
Gnomad ASJ exome
AF:
0.00258
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000317
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00211
AC:
3088
AN:
1461820
Hom.:
84
Cov.:
32
AF XY:
0.00182
AC XY:
1321
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.0689
AC:
2305
AN:
33472
American (AMR)
AF:
0.00396
AC:
177
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
38
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00537
AC:
31
AN:
5768
European-Non Finnish (NFE)
AF:
0.000182
AC:
202
AN:
1111974
Other (OTH)
AF:
0.00541
AC:
327
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
160
320
480
640
800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0199
AC:
3030
AN:
152270
Hom.:
96
Cov.:
32
AF XY:
0.0190
AC XY:
1413
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0684
AC:
2843
AN:
41536
American (AMR)
AF:
0.00811
AC:
124
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68036
Other (OTH)
AF:
0.0166
AC:
35
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
145
290
434
579
724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0115
Hom.:
86
Bravo
AF:
0.0231
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital afibrinogenemia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
6.4
DANN
Benign
0.69
PhyloP100
-0.29
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6058; hg19: chr4-155490344; API